PATENT CLAIM ANALYSIS

Application Number: 15772587
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["544", "262000"]

Abstract:
Compounds of the formula I in which Z, W, Q, R and Y have the meanings indicated in claim  1 , are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

Claim (Index 3):
Process for the preparation of compounds of the formula according to  claim 1  and pharmaceutically acceptable salts, solvates, tautomers and stereoisomers thereof, characterised in that a compound of the formula II in which Y has the meanings indicated in  claim 1 , is reacted with a compound of formula III\n Z-W-Q-R\u2014C(\u2550O)-L\u2003\u2003III \n in which Z, W, Q and R have the meanings indicated in  claim 1 , and L denotes Cl, Br, I or a free or reactively functionally modified OH group, and/or a base or acid of the formula I is converted into one of its salts.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 93.0
- Lexical Diversity: 1.40476
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14909365', '15308974', '13383605', '16069326', '14378009']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7896856466786362
- 35 USC 102 Novelty (BERT): 0.5620583311079143
- Combined Prediction Score: 0.766922915121564
- Mean Citation Score: 375.466308
- Max Citation Score: 428.29956
- Similarity Product: 385.01237579006187

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test